## Gilead Sciences Refuses Direct Sale of HIV Prevention Drug to Doctors Without Borders, Sparking 'Unconscionable' Criticism
Doctors Without Borders has launched a sharp public rebuke of Gilead Sciences, labeling the pharmaceutical giant's refusal to sell a groundbreaking HIV prevention drug directly to humanitarian organizations as 'unconscionable.' The criticism centers on lenacapavir, a long-acting injectable that offers virtually complete protection from HIV infection with just two shots per year. This direct-access denial creates a significant bottleneck for frontline medical groups aiming to deploy the most effective prevention tools in vulnerable communities.

The conflict follows months of failed negotiations where Doctors Without Borders requested a limited supply of lenacapavir from Gilead. Currently, the organization can only access the drug through an intermediary, The Global Fund to Fight AIDS, Tuberculosis and Malaria. While The Global Fund secured a late-2024 deal with Gilead to distribute the treatment to 2 million people in low- and middle-income countries, the manufacturer's policy blocks direct sales to NGOs. This forces humanitarian operations into a more complex and potentially slower procurement chain, separate from established commercial or large-scale institutional channels.

The standoff highlights a critical tension in global health equity: who controls access to medical breakthroughs. Gilead's decision maintains its centralized distribution model through a major partnership, but it simultaneously restricts the operational agility of groups like Doctors Without Borders that often work in the most challenging and urgent contexts. The refusal raises immediate questions about the sufficiency and flexibility of existing access agreements to meet real-time crisis needs, putting pressure on the pharmaceutical industry's humanitarian engagement frameworks.
---
- **Source**: STAT News
- **Sector**: The Lab
- **Tags**: Pharmaceuticals, HIV Prevention, Global Health Access, Drug Pricing, Non-Governmental Organizations
- **Credibility**: unverified
- **Published**: 2026-03-30 20:27:12
- **ID**: 41793
- **URL**: https://whisperx.ai/en/intel/41793